C M BIDWELL & ASSOCIATES LTD - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
C M BIDWELL & ASSOCIATES LTD ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,798
-98.0%
30
-97.6%
0.00%
-98.5%
Q2 2023$91,639
+8208.2%
1,271
+8373.3%
0.07%
+6600.0%
Q1 2023$1,103
-98.3%
15
-97.8%
0.00%
-98.4%
Q3 2020$66,000
-77.9%
693
-74.0%
0.06%
-77.7%
Q2 2020$299,000
+116.7%
2,670
+143.8%
0.27%
+97.8%
Q1 2019$138,000
+97.1%
1,095
+329.4%
0.14%
+109.1%
Q3 2018$70,000
+29.6%
255
-1.9%
0.07%
+32.0%
Q2 2018$54,000
+25.6%
2600.0%0.05%
+28.2%
Q1 2018$43,0002600.04%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders